Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

Feasibility Assessment of Zolidd-One-Exhex Dental Implant

Reference number
Coordinator Addbio AB
Funding from Vinnova SEK 500 000
Project duration August 2017 - January 2018
Status Completed

Purpose and goal

The aim of the project was to develop a business plan for the continued development of ZoliddOne-Exhex- an implant that fully integrates a nanometre-thin bioactive layer of bonestrengthening pharmaceuticals. We have achieved the project´s goals.

Expected results and effects

The project has accelerated the market penetration and deployment of Zolidd-One-Exhex on the European market, creating a firm basis for establishing European and international brand recognition for the Zolidd® technology and allowing AddBIO to establish itself as the leading provider of bonestrengthening technology for dental implants. The result will be a long-term competitive advantage and potential for growth.

Planned approach and implementation

The key methods applied in the project included: desk research, analysis of the primary and secondary market data and KOL interviews. The project was divided into three work packages: Strategic Business Review, Business Model Visioning and Business Plan Development and Formulation. The project time was six months.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 14 June 2019

Reference number 2017-03359

Page statistics